Cite
HARVARD Citation
Hansen, M. et al. (2023). GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells. European journal of endocrinology. 188 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hansen, M. et al. (2023). GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells. European journal of endocrinology. 188 (1), p. . [Online].